AI assistant
Sending…
LEMAITRE VASCULAR INC — Director's Dealing 2024
Mar 26, 2024
31708_dirs_2024-03-26_233de5fb-9e17-4dec-9ab7-6dd6457e5710.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2024-03-22
Reporting Person: LeMaitre George W (Director, Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-22 | Common Stock | M | 7075 | $47.19 | Acquired | 2194601 | Direct |
| 2024-03-22 | Common Stock | M | 7733 | $48.60 | Acquired | 2202334 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-22 | Stock Option (Right to Buy) | $48.60 | M | 7733 | Disposed | 2028-12-11 | Common Stock (7733) | Direct |
| 2024-03-22 | Stock Option (Right to Buy) | $47.19 | M | 7075 | Disposed | 2029-12-12 | Common Stock (7075) | Direct |
Footnotes
F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the forth anniversary.
More from LEMAITRE VASCULAR INC
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Apr 14
Annual Report
2026
Apr 14
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3